Home Emerging Therapy Aptar Pharma and BD Announce Deal to Bring New Auto-Injector to Market

Aptar Pharma and BD Announce Deal to Bring New Auto-Injector to Market

-

French drug delivery solutions provider Aptar Pharma announced an exclusive deal with Becton, Dickinson and Company (BD) to develop and commercialize a novel auto-injector based on Aptar’s two-step device and BD’s prefillable syringes.

BD is a leading manufacturer of syringes including the BD Hypak prefillable syringe. Aptar currently markets Pro-Ject™, a relatively small, lightweight disposable auto-injector used for delivery of biologics and other drugs.

Click to visit sponsor

Aptar’s auto-injector was specifically designed around BD’s stable of prefilled syringes and the company claims to hold a number of patents on the design. Under the agreement, BD – a global medical technology firm – will commercialize the product.

Here is Aptar’s video showing the design features and administration of Pro-Ject:

As the device is being developed to deliver a variety of drugs across a range of applications, the economies of scale could potentially result in a lower cost alternative for epinephrine delivery.

Print or share this article

Click to visit sponsor
Dave Bloom
Dave Bloom is CEO and "Blogger in Chief" of SnackSafely.com.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.